Exploiting new targets for old bones.
Rosen
Clifford J
CJ
Maine Medical Center Research Institute, Scarborough, ME 04074, USA.
D048868:Adaptor Proteins, Signal Transducing; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D019485:Bone Morphogenetic Proteins / Q000037:antagonists & inhibitors; D016723:Bone Remodeling / Q000187:drug effects*; D001862:Bone Resorption / Q000517:prevention & control*; D056657:Cathepsin K / Q000037:antagonists & inhibitors*; D005819:Genetic Markers; D006801:Humans; D010010:Osteoclasts / Q000187:drug effects*
D048868:Adaptor Proteins, Signal Transducing; D000911:Antibodies, Monoclonal; D001713:Biphenyl Compounds; D019485:Bone Morphogenetic Proteins; D005819:Genetic Markers; C422903:SOST protein, human; D056657:Cathepsin K; C527128:odanacatib